Ethical issues in the use of tumor markers in clinical investigation of the management of bladder cancer

By McCullough L.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 1, 2002-01 ,pp. : 35-37

Elsevier

Access to resources Recommend Favorite

Application of Tumor Markers CEA, TPA, and SCC-Ag in Patients with Low-Risk FIGO Stage IB and IIA Squamous Cell Carcinoma of the Uterine Cervix

By Juang C.-M.   Wang P.-H.   Yen M.-S.   Lai C.-R.   Ng H.-T.   Yuan C.-C.  

Gynecologic Oncology, Vol. 76, Iss. 1, 2000-01 ,pp. : 103-106

Elsevier

Access to resources Recommend Favorite

Quantification Techniques and Biodistribution of Semiconductor Quantum Dots

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 3, 2009-03 ,pp. : 295-303

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor markers in prostate cancer I: Blood-based markers

By Shariat Shahrokh F.   Semjonow Axel   Lilja Hans   Savage Caroline   Vickers Andrew J.   Bjartell Anders  

Acta Oncologica, Vol. 50, Iss. 1, 2011-06 ,pp. : 61-75

Informa Healthcare

Access to resources Recommend Favorite

Advances in Cancer Investigation

By Lyman Gary  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 515-516

Informa Healthcare

Access to resources Recommend Favorite